Biochemical alterations from normal mucosa to gastric cancer by ex vivo magnetic resonance spectroscopy

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 6, 2008, Pages 1386-1395

  Calabrese, Carlo ^a   Pisi, Annamaria ^a   Di Febo, Giulio ^a   Liguori, Giuseppina ^a   Filippini, Gianfranco ^a   Cervellera, Maurizio ^a   Righi, Valeria ^a,c   Lucchi, Patrizia ^a   Mucci, Adele ^c   Schenetti, Luisa ^c   Tonini, Valeria ^a   Tosi, Maria Raffaella ^b   Tugnoli, Vitaliano ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; BIOLOGICAL MARKER; CHOLINE; GLUTARALDEHYDE; GLYCINE; LIQUID NITROGEN; TRIACYLGLYCEROL;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; AUTOIMMUNE ATROPHIC GASTRITIS; BIOCHEMISTRY; CARCINOGENESIS; CELL HYPOXIA; CELL ULTRASTRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENDOSCOPY; EX VIVO STUDY; FEMALE; GASTRECTOMY; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN VIVO STUDY; INFRARED SPECTROSCOPY; LIPID STORAGE; MALE; MITOCHONDRION; MOLECULAR BIOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMACH MUCOSA;

ADENOCARCINOMA; AGED; ALANINE; CHOLINE; ENDOSCOPY, GASTROINTESTINAL; FEMALE; GASTRECTOMY; GASTRIC MUCOSA; GASTRITIS, ATROPHIC; GLYCINE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS; STOMACH NEOPLASMS; TRIGLYCERIDES; TUMOR MARKERS, BIOLOGICAL;

EID: 53349090641     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-2676     Document Type: Article

References (46)

1. Correa P. A human model for gastric carcinogenesis. Cancer Res 1988;48:3554-60.
2. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001;49:347-53.
3. Meining A, Bayerdorffer E, Muller P, et al. Gastric carcinoma risk index in patients infected with Helicobacter pylori. Virchows Arch 1998;432:311-4.
4. Correa P. Chronic gastritis: a clinic-pathological classification. Am J Gastroenterol 1988;83:504-9.
5. 1H-NMR-detectable mobile lipid domains in NIH-3T3 fibroblasts. Biochim Biophys Acta 1999;1438:329-48.
6. Nuclear magnetic resonance spectroscopy in the study of neoplastic tissue. In: Tosi R, Tugnoli V, editors. New York: Nova Science Publishers, Inc.; 2005.
7. Gillies RJ, Morse DL. In vivo magnetic resonance spectroscopy in cancer. Annu Rew Biomed Eng 2005;7:287-326.
8. Tugnoli V, Schenetti L, Mucci A, et al. Ex vivo HR-MAS MRS of human meningiomas: a comparison with in vivo 1H MR spectra. Int J Mol Med 2006;18:859-69.
9. Celda B, Monleon D, Martinez-Bisbal MC, et al. MRS as endogenous molecular imaging for brain and prostate tumor: FP6 project "e TUMOR". Adv Exp Med Biol 2006;587:285-302.
10. 1H MR spectroscopy for assessment of apoptosis in cervical carcinomas. BMC Cancer 2007;17:7-11.
11. 1H-MRS) for evaluation of human gastric carcinoma. Magn Reson Imaging 2004;22:861-70.
12. Tugnoli V, Mucci A, Schenetti L, et al. Molecular characterization of human gastric mucosa by HR-MAS magnetic resonance spectroscopy. Int J Mol Med 2004;14:1065-71.
13. Tugnoli V, Mucci A, Schenetti L, et al. Ex vivo HR-MAS magnetic resonance spectroscopy of human gastric adenocarcinomas: a comparison with healthy gastric mucosa. Oncol Rep 2006;16:543-54.
14. Schenetti L, Mucci A, Parenti F, et al. HR-MAS MMR spectroscopy in the characterization of human tissues: application to healthy gastric mucosa. Concepts Magn Reson 2006;28A:430-43.
15. Podo F. Tumour phospholipid metabolism. NMR Biomed 1999;12:413-39.
16. Glunde K, Jie C, Bhujwalla ZM. Molecular causes of the aberrant choline phospholipid metabolism in breast cancer. Cancer Res 2004;64:4270-6.
17. Iorio E, Mezzanzanica D, Alberti P, et al. Alterations of choline phospholipid metabolism in ovarian tumor progression. Cancer Res 2005;65:9369-76.
18. Glunde K, Ackerstaff E, Mori N, Jacobs MA, Bhujwalla ZM. Choline phospholipids metabolism in cancer: consequences for molecular pharmaceutical interventions. Mol Pharm 2006;3:496-506.
19. Janardhan S, Srivani P, Sastry GN. Choline kinase: an important target for cancer. Curr Med Chem 2006;13:1169-86.
20. Ramírez de Molina A, Gallego-Ortega D, Sarmentero-Estrada J, et al. Choline kinase as a link connecting phospholipid metabolism and cell cycle regulation: implications in cancer therapy. Int J Biochem Cell Biol. In press 2008.
21. Foster DA, Xu L. Phospholipase D in cell proliferation and cancer. Mol Canc Res 2003;1:798-800.
22. Noh DY, Ahn SJ, Lee RA, et al. Overexpression of phospholipase D1 in human breast cancer tissue. Cancer Lett 2000;161:207-14.
23. Uchida N, Okamura S, Nagamachi Y, Yamashita S. Increased phospholipase D activity in human breast cancer. J Cancer Res Clin Oncol 1997;123:280-5.
24. Zhao Y, Ehara H, Akao Y, et al. Increased activity and intranuclear expression of phospholipase D2 in human renal cancer. Biochem Biophys Res Commun 2000;278:140-3.
25. Uchida N, Okamura S, Kuwano H. Phospholipase D activity in human gastric carcinoma. Anticancer Res 1999;19:671-5.
26. Rodriguez-Gonzalez A, Ramirez de Molina A, Benitez-Rajal J, Lacal JC. Phospholipase D and choline kinase: their role in cancer development and their potential as drug target. Progress in Cell Cycle Res 2003;5:191-201.
27. Griffin JL, Shockor JP. Metabolic profiles of cancer cells. Nat Rev Cancer 2004;4:551-61.
28. Finch PJ, Ryan FP, Rogers K, Holt S. Gastric enzymes as a screening test for gastric cancer. Gut 1987;28:319-22.
29. 1H NMR spectroscopic investigation. NMR Biomed 2005;18:371-82.
30. 1H magic angle spinning (MAS) NMR spectra. NMR Biomed 2000;13:64-71.
31. Sitter B, Lundgren S, Bathen Tone F, Halgunset J, Fjosne HE, Gribbestadt IS. Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters. NMR Biomed 2006;19:30-40.
32. Griffiths JR, McSheehy PMJ, Robinson SP, et al. Metabolic changes detected by in vivo magnetic resonance studies of HEPA-1 wild-type tumors and tumors deficient in hypoxia-inducible factor-1b (HIF-1b): evidence of an anabolic role for the HIF-1 pathway. Cancer Res 2002;62:688-95.
33. Mizokami K, Kakeji Y, Oda S, et al. Clinicopathologic significance of hypoxia-inducible factor 1α overexpression in gastric carcinomas. J Surg Oncol 2006;94:149-54.
34. Griffiths EA, Pritchard SA, Valentine HR, et al. Hypoxia-inducible factor-1α expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas. Br J Cancer 2007;96:95-103.
35. Zhong H, De Marzo AM, Laughner E, et al. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res 1999;59:5830-5.
36. Park JH, Kim TY, Jong HS, et al. Gastric epithelial reactive oxygen species prevent normoxic degradation of hypoxia-inducible factor-1α in gastric cancer cells. Clin Cancer Res 2003;9:433-40.
37. Tosi MR, Fini G, Tinti A, Reggiani A, Tugnoli V. Molecular characterization of human healthy and neoplastic cerebral and renal tissues by in vitro 1H NMR spectroscopy [review]. Int J Mol Med 2002;9:299-310.
38. Bourne RM, Stanwell P, Stretch JR, et al. In vivo and ex vivo proton MR spectroscopy of primary and secondary melanoma. Eur J Radiol 2005;53:506-13.
39. Ben Yoseph O, Baddar-Goffer RS, Morris PG, Bachelard HS. Glycerol 3-phosphate and lactate as indicators of the cerebral cytoplasmic redox state in severe and mild hypoxia respectively: a carbon-13 and phosphorus-31 NMR study. Biochem J 1993;291:915-9.
40. Golman K, In't Zandt R, Thaning M. Real-time metabolic imaging. Proc Natl Acad Sci U S A 2006;103:11270-5.
41. 1H NMR-visible mobile lipids and lipid bodies in HuT 78 apoptotic cells. Biochim Biophys Acta 2003;1634:1-14.
42. Hakumaki JM, Kauppinen RA. 1H NMR visible lipids in the life and death of cells. Trends Biochem Sci 2000;25:357-62.
43. Goto K, Asai T, Hara S, et al. Enhanced antitumor activity of xanthohumol, a diacylglycerol acyltransferase inhibitor, under hypoxia. Cancer Lett 2005;219:215-22.
44. Freitas I. Lipid accumulation: the common feature to photosensitizer- retaining normal and malignant tissues. J Photochem Photobiol B 1990;7:359-61.
45. Freitas I, Bono B, Bertone V, et al. Characterization of the metabolism of perinecrotic cells in solid tumors by enzyme histochemistry. Anticancer Res 1996;16:1491-502.
46. Zoula S, Herigault G, Ziegler A, Farion R, Decorps M, Remy C. Correlation between the occurrence of 1H-MRS lipid signal, necrosis and lipid droplets during C6 rat glioma development. NMR Biomed 2003;16:199-212.